Definium Therapeutics Reports Positive Phase 3 Results
Definium Therapeutics announces positive topline results from Phase 3 Voyage Study of DT120 ODT
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.